Lyra Therapeutics (LYRA) Return on Capital Employed Growth (1y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 2,503.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -105.00 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 2,400.00 |
| 10 | Lyra Therapeutics | - | - | - | 5,870.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,870.00 |
| Sep 30, 2025 | 5,008.00 |
| Jun 30, 2025 | 1,119.00 |
| Mar 31, 2025 | -10,433.00 |
| Dec 31, 2024 | -10,086.00 |
| Sep 30, 2024 | -7,808.00 |
| Jun 30, 2024 | -4,042.00 |
| Mar 31, 2024 | 1,084.00 |
| Dec 31, 2023 | -377.00 |
| Sep 30, 2023 | -1,404.00 |
| Jun 30, 2023 | -132.00 |
| Mar 31, 2023 | 9,342.00 |
| Dec 31, 2022 | 4,510.00 |
| Sep 30, 2022 | 1,893.00 |
| Jun 30, 2022 | -1,835.00 |
| Mar 31, 2022 | -12,824.00 |
| Dec 31, 2021 | -7,323.00 |
| Sep 30, 2021 | -4,532.00 |
| Jun 30, 2021 | -1,930.00 |
| Mar 31, 2021 | 4,002.00 |